Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Issuance( Retirement)of Debt Net | -0.89 | 33.49 | 0.36 | -0.25 |
Net Changein Cash | -0.06 | 0.17 | 0.07 | -0.18 |
Cash Taxes Paid | 0.73 | 0.20 | 0.08 | 0.03 |
Net Income/ Starting Line | 3.23 | 1.68 | 0.55 | 0.17 |
Changesin Working Capital | -15.20 | -42.05 | -1.16 | -1.74 |
Cashfrom Operating Activities | -8.77 | -38.95 | 0.24 | -0.78 |
Cash Interest Paid | 3.08 | 1.32 | 0.74 | 0.66 |
Cashfrom Financing Activities | 8.32 | 40.34 | -0.15 | 0.67 |
Issuance( Retirement)of Stock Net | 6.97 | 8.18 | 0.23 | 1.58 |
Depreciation/ Depletion | 0.12 | 0.10 | 0.11 | 0.13 |
Other Investing Cash Flow Items Total | 0.57 | -0.59 | 0.00 | 0.00 |
Capital Expenditures | -0.18 | -0.63 | -0.01 | -0.06 |
period Type | - | - | - | - |
Non- Cash Items | 3.08 | 1.32 | 0.74 | 0.66 |
Financing Cash Flow Items | 2.24 | -1.32 | -0.74 | -0.66 |
period Length | 12.00 | 12.00 | 12.00 | 12.00 |
Cashfrom Investing Activities | 0.40 | -1.22 | -0.01 | -0.06 |
Mono Pharmacare Dividend Mono Pharmacare Bonus Mono Pharmacare News Mono Pharmacare AGM Mono Pharmacare Rights Mono Pharmacare Splits Mono Pharmacare Board Meetings Mono Pharmacare Key Metrics Mono Pharmacare Shareholdings Mono Pharmacare Profit Loss Mono Pharmacare Balance Sheet Mono Pharmacare Q1 Results Mono Pharmacare Q2 Results Mono Pharmacare Q3 Results Mono Pharmacare Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks